NIHR Maudsley BRC Blog

Our latest news and events

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021

SIREN study finds past COVID-19 infection provides some immunity for at least five months

The first report from Public Health England's national SIREN study, supported at King's College Hospital by the King's CRF, has found that past COVD-19 infection provides 83% immunity for at least five months. However, some people may still carry the virus and transmit to other people.

By NIHR Wellcome King's Clinical Research Facility at 19 Jan 2021

New swabbing pod open at King's CRF

A new swabbing pod has been installed next to the Clinical Trials Facility at King’s College Hospital so that outpatients and trial participants who are symptomatic or have tested positive for COVID-19 can continue to receive treatment or attend follow-up appointments.

By NIHR Wellcome King's Clinical Research Facility at 8 Dec 2020

Cluster headache research features on the BBC

Research into cluster headaches taking place at the NIHR Wellcome King's Clinical Research Facility features on BBC Breakfast and BBC Radio 5 live

By NIHR Wellcome King's Clinical Research Facility at 5 May 2017

UK Government announces £4m investment in NIHR Wellcome Trust King’s Clinical Research Facility

UK Government announces £4 million investment in NIHR-Wellcome Trust King’s Clinical Research Facility. 

By NIHR Wellcome King's Clinical Research Facility at 18 Nov 2016